Home › Funds › INFINITUM ASSET MANAGEMENT, LLC › BNTC

INFINITUM ASSET MANAGEMENT, LLC position in BNTC

BENITEC BIOPHARMA INC · Health Care

INFINITUM ASSET MANAGEMENT, LLC reported holding 923,006 shares of BNTC (BENITEC BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 1.26% of its reported portfolio and ranking #13 among its reported holdings. INFINITUM ASSET MANAGEMENT, LLC has disclosed BNTC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)923.01K sh
Reported value held$12.35M
Portfolio Weight1.26%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How INFINITUM ASSET MANAGEMENT, LLC's BNTC position evolved

INFINITUM ASSET MANAGEMENT, LLC first disclosed a stake in BNTC in Q4 2024 at 210,000 shares (US$2.7M). The position peaked in Q1 2025 at 1,125,000 shares, worth US$18.9M. Across 7 filings, INFINITUM ASSET MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 923,006 shares valued at US$12.3M. Notable position changes include a 436% increase in Q1 2025 (shares fell 10% over the following quarter), a 56% trim in Q2 2025 (shares rose 20% over the following quarter), a 80% increase in Q4 2025 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 210.00K $2.65M New
Q1 2025 1.12M $18.91M Add
Q2 2025 500.00K $5.85M Reduce
Q3 2025 500.00K $7.01M Hold
Q4 2025 898.87K $12.11M Add
Q1 2026 923.01K $9.83M Add
Q2 2026 923.01K $12.35M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTC and 13F data

BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 56 other funds we track also report a position in BNTC — the largest reported positions include MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTC

All BNTC fund holders →

FAQ

How long has INFINITUM ASSET MANAGEMENT, LLC held BNTC?

INFINITUM ASSET MANAGEMENT, LLC has disclosed BNTC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is INFINITUM ASSET MANAGEMENT, LLC's current position in BNTC?

As of Q2 2026, INFINITUM ASSET MANAGEMENT, LLC holds 923.01K shares of BNTC (BENITEC BIOPHARMA INC), valued at $12.35M, representing 1.26% of its reported portfolio and ranking #13.

Has INFINITUM ASSET MANAGEMENT, LLC been buying or selling BNTC?

In the latest 13F filing (Q2 2026), INFINITUM ASSET MANAGEMENT, LLC held unchanged its position in BNTC. The position peaked in Q1 2025 at 1.12M shares.

Which other funds hold BNTC?

Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, Simplify Asset Management Inc., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.